In these studies, researchers apply GHK-Cu to standardized incisions or excisional wounds and monitor outcomes such as the rate of wound closure, re-epithelialization, granulation tissue formation, and angiogenesis
For individuals in the UK seeking evidence-based treatments for hair loss, the following options have established clinical support: Topical minoxidil: Licensed by the MHRA for androgenetic alopecia in both men and women (available as a 2% or 5% cutaneous solution or foam
Developed in collaboration with health tech company Prenetics , IM8 enters the competitive wellness market with bold claims, a 92-ingredient daily powder, and a sleek brand image
Cell 169 , 132147.e16 (2017)
Pre-reconstituted solutions Some suppliers offer GHK-Cu already reconstituted
Lower cagrilintide doses in combinations When combining, can reduce cagrilintide: 1.8mg cagrilintide + 2.4mg semaglutide: Still very effective (14-18% weight loss estimated) Better tolerated than both at 2.4mg Cost savings on cagrilintide Consider if GI-sensitive 1.2mg cagrilintide + 2.4mg semaglutide: Modest benefit from cagrilintide addition Minimal GI side effects from cagrilintide Semaglutide does heavy lifting May still achieve 12-15% total weight loss Testing approach: Start with standard doses (both 2.4mg) If intolerable, reduce cagrilintide first Maintain semaglutide at 2.4mg (well-tolerated, established) Find optimal cagrilintide dose for your tolerance Maintenance dosing after weight loss Strategies to sustain results long-term
